Search for: "Biogen Idec, Inc." Results 81 - 100 of 113
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Mar 2016, 3:23 am
Never too late 85 [week ending on Sunday 28 February] – AG Yves Bot's take in Reha Training | Battistelli having hard times | Blocking injunctions in trade mark cases | AIPPI UK event | Patent Enforcement Worldwide | Why Mickey Mouse is not mickey mouse | UPC court fees.Never too late 84 [week ending on Sunday 21 February] – Domain Name Law and Practice | Unwired Planet v Huawei and Samsung | In… [read post]
17 Dec 2010, 11:18 am by Matt Osenga
Biogen IDEC, where the Federal Circuit issued a ridiculous one paragraph merits opinion rejecting a claim to a method of determining an immunization schedule. [read post]
10 Sep 2011, 12:32 am by Marie Louise
(Spicy IP) (Spicy IP) US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al / ????????????????????????? [read post]
23 Oct 2008, 10:31 am
" Meanwhile, "Rituxan (rituximab), which Genentech sells with Biogen-Idec Inc. for lymphoma, caused rare cases of...progressive multifocal leukoencephalopathy (PML)," a condition that "is also tied to Biogen's multiple sclerosis drug Tysabri (natalizumab). [read post]
7 Jan 2015, 6:54 am
Biogen Idec Inc., 2014 WL 2882104, at *3 (W.D.N.Y. [read post]
18 May 2012, 5:45 am by paperstreet
Biogen IDEC, Nos. 2006-1634, 2006-1649, 2011 WL 3835409, at *6 (Fed. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb)   General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
27 Feb 2010, 3:23 pm by Andis Kaulins
Biogen Idec presaged how arbitrary the Bilski test can be when applied to such drug/medical dosage calibration techniques. [read post]
13 Aug 2015, 10:56 am
Biogen Idec, Inc. is a case involving a brand-name pharmaceutical product which held that design defect claims against drug manufacturers are preempted as a matter of law. [read post]
12 Dec 2011, 9:02 am by Shane Cortesi
Biogen Idec, the three patents at issue were related to a method of reducing the risk of chronic immune-mediated disorders by choosing a particular immunization schedule. [read post]